Lin Xichen

CHIEF SCIENTIFIC OFFICERStructure Therapeutics Inc. (GPCR) · full profile →Form 4 · filed Sep 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 1, 2026Option exercise(M)18K$0.34$6K247K
Sep 1, 2026Conversion(C)18K$0229K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2026Option exercise(M)18K$0125K
Sep 1, 2026Conversion(C)6K$06K
Sep 1, 2026Sell(S)1K$45.86$60K5K
Sep 1, 2026Sell(S)5K$47.20$214K100
Sep 1, 2026Sell(S)100$47.83$5K0

Transaction Codes

M
Option exercise / conversion
C
Conversion of a derivative
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001962926-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.